5-(Trifluoromethyl)-1,3-thiazole-2-carbaldehyde

Catalog No. :
ACAKHD385
CAS No. :
1379174-19-2
Molecular Formula :
C5H2F3NOS
Molecular Weight :
181.14

IUPAC Name:5-(trifluoromethyl)thiazole-2-carbaldehyde

5-(Trifluoromethyl)-1,3-thiazole-2-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg94%$379.00Login to see priceInquiryInquiry
100mg94%$554.00Login to see priceInquiryInquiry
250mg94%$784.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Trifluoromethyl)-1,3-thiazole-2-carbaldehyde
IUPAC Name5-(trifluoromethyl)thiazole-2-carbaldehyde
MDL No.MFCD11846868
Molecular FormulaC5H2F3NOS
Molecular Weight181.14
SMILESO=CC1=NC=C(C(F)(F)F)S1
InChI KeyGXVQGBUDNIUMEZ-UHFFFAOYSA-N
Synonym5-(trifluoromethyl)thiazole-2-carbaldehyde;5-(Trifluoromethyl)-1,3-thiazole-2-carbaldehyde;2-Thiazolecarboxaldehyde, 5-(trifluoromethyl)-;5-(trifluoromethyl)-1,3-thiazole-2-carbaldehyde5-(trifluoromethyl)-1,3-thiazole-2-carbaldehyde;5-(Trifluoromethyl)-1,3-thiazol-2-carbaldehyde5-(trifluoromethyl)-1,3-thiazol-2-carbaldehyde;5-(Trifluoromethyl)-thiazol-2-carbaldehyde
CAS No.1379174-19-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACAKHD385 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAKHD385 route product structure diagram
    ACAKHD3851379174-19-2
Inquiry

2. ACAKHD385 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAKHD385 route product structure diagram
    ACAKHD3851379174-19-2
Inquiry

Comments (0)